Position in COLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,160,756
+$1,140,844 QoQ
Shares Held
556,927
-3.2% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Derivatives in COLL
reported options exposure · as of Mar 31, 2020CallValue
$408,250
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. COLL ranks #21 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in COLL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,160,756 | 556,927 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,019,912 | 575,141 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,980,962 | 647,537 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $28,070,166 | 802,234 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,001,879 | 236,790 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,233,301 | 175,320 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,294,719 | 219,711 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $22,227,234 | 575,239 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,125,872 | 345,524 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,364,538 | 163,950 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,311,808 | 205,062 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,671,194 | 209,002 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $4,573,436 | 212,817 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,807,573 | 117,031 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,045,961 | 88,188 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $1,651,805 | 103,109 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,083,063 | 61,121 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,052,348 | 100,803 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,766,881 | 148,120 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $3,651,307 | 184,970 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $4,193,380 | 177,385 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,502,928 | 189,997 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,328,368 | 66,319 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $939,522 | 45,126 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,367,292 | 78,131 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $408,250 | 25,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $1,755,442 | 107,498 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||